Search

everythinglearnresearchcommunity

for

Search:↓

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

The document lists dermatology topics across life stages and notes hair loss can affect self-esteem and early skin cancer treatment is crucial.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Hair loss affects self-esteem and quality of life; treatments can help.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Most women with weird scalp feelings had neck spine problems, and some got better with gabapentin treatment.

A new method was created to measure metformin in hair, showing potential for monitoring treatment and medical investigations.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

PCOS affects women's hormones and metabolism, but can be managed with lifestyle changes and treatments.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

Rhabdomyosarcoma is the most common head and neck cancer in children, requiring complex treatment.

Blood stasis is the main cause of spot baldness, and treatments should focus on improving blood circulation.

Some plant extracts may treat livestock diseases, certain animal treatments are safe and effective, but more research on drug safety and resistance is needed.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.